In this episode of the NIH Collaboratory Grand Rounds podcast, Dr. Andrew Faucett of Geisinger speaks with moderator Dr. Lesley Curtis about the return of genomic results. A key consideration for returning results of this type of research to patients and clinicians is how to scale it, as there can be issues with technical validity and sample identity in genetic variants. He describes the need to appropriately define what we can and cannot interpret from the information, and do a better job of making tools for patient use of raw data.
Click on the recording below to listen to the podcast.
|Want to hear more from Dr. Faucett and his colleague, Dr. Heidi Rehm? View the full Grand Rounds presentation.
We encourage you to share this podcast with your colleagues and tune in for our next episode with Grand Rounds speakers Drs. Sean Tunis and Ellen Tambor and their presentation “Straight from the Source: Clinicians’ Views on Participating in CER/PCOR,” which will be posted the week of March 26.